Phathom Pharmaceuticals Announces Commercial Availability
VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available at major retail pharmacies and through BlinkRx....
Source: globenewswire.com
Eric Sciorilli News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Sciorilli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Sciorilli Today - Breaking & Trending Today
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®
FDA approval marks the first major innovation to the U.S. Erosive GERD market in over 30 yearsVOQUEZNA® met the primary endpoints and key secondary...
Source: globenewswire.com
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
25.10.2023 - FLORHAM PARK, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) - Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members ...
Source: wallstreet-online.de
Phathom Pharmaceuticals Announces Vonoprazan NDA Submission for Non-Erosive GERD
Submission based on positive results from Phase 3 PHALCON-NERD-301 in which vonoprazan 10 mg and 20 mg controlled heartburn symptoms through the e...
Source: businessinsider.com
Phathom Pharmaceuticals Announces Submission of Six-Month Stability Data in Support of Erosive GERD New Drug Application
Six-month stability data remain more than 10x below the acceptable intake limit set by the U.S. Food and Drug Administration and continue to support the requested product shelf lifeSubmission of...
Source: marketscreener.com